A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology

• Published in: Thorax Vol. 62; no. 3; pp. 242 - 247
• Main Authors: Gosman, Margot M E, Marike Boezen, H, van Diemen, Cleo C, Snoeck-Stroband, Jiska B, Lapperre, Thérèse S, Hiemstra, Pieter S, ten Hacken, Nick H T, Stolk, Jan, Postma, Dirkje S
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group Ltd and British Thoracic Society 01-03-2007; BMJ; BMJ Publishing Group LTD; BMJ Group
• Subjects: 20% fall in forced expiratory volume in 1 s; a disintegrin and metalloprotease 33; ADAM Proteins - genetics; ADAM33; AHR; Air flow; airway hyper-responsiveness; Airway management; Analysis of Variance; Asthma; Biological and medical sciences; Biopsy; Bronchi - pathology; Bronchial Hyperreactivity - genetics; Bronchitis - genetics; Chronic Obstructive Pulmonary Disease; Chronic obstructive pulmonary disease, asthma; COPD; Eosinophils - metabolism; Female; FEV; forced expiratory volume; Genotype & phenotype; Haplotypes; Humans; Inflammation; Male; Mast Cells - metabolism; Medical sciences; Middle Aged; Patients; PC20; Pneumology; Polymorphism, Single Nucleotide - genetics; Pulmonary Disease, Chronic Obstructive - genetics; Regression analysis; single nucleotide polymorphism; Smoking; SNP; Sputum - cytology; Netherlands; Lung disease; Chronic; Pathophysiology; Respiratory disease; Pathogenesis; Chronic disease; Bronchus disease; Cardiovascular disease; Obstructive pulmonary disease
• ISSN: 0040-6376; 1468-3296
• DOI: 10.1136/thx.2006.060988

Background: Chronic obstructive pulmonary disease (COPD) is a respiratory disorder with increasing prevalence and mortality. It is associated with airway obstruction, increased airway hyper-responsiveness (AHR), and ongoing airway and lung inflammation dominated by CD8 lymphocytes and neutrophils. Single-nucleotide polymorphisms (SNPs) in a disintegrin and metalloprotease 33 (ADAM33) gene have been associated with AHR and COPD. Objective: To assess whether SNPs in ADAM33 are associated with the severity of AHR and airway inflammation in COPD. Methods: Eight SNPs in ADAM33 (F+1, Q-1, S_1, S_2, ST+5, T_1, T_2, V_4) were genotyped in 111 patients with COPD (96 males, 69 current smokers, mean (standard deviation (SD)), aged 62 (8) years, median pack-years 42 (IQR 31–55), mean postbronchodilator forced expiratory volume in 1 s (FEV1)% predicted 63 (9). Provocative concentration of methacholine causing a decrease in FEV1 of 20% (PC20 methacholine), sputum and bronchial biopsies were collected. Results: Patients with the ST+5 AA genotype had more severe AHR, higher numbers of sputum inflammatory cells and CD8 cells in bronchial biopsies than patients with the GG genotype (p = 0.03, 0.05 and 0.01, respectively). CD8 cell numbers were lower in patients carrying the minor allele of SNP T_1 and T_2, and homozygotic minor variants of SNP S_2 compared with the wild type (p = 0.02, 0.01 and 0.02, respectively). Conclusions: This is the first study revealing that SNPs in a gene that confers susceptibility to COPD in the general population—that is, ADAM33—are associated with AHR and airway inflammation in COPD. These findings constitute an important step forward in linking gene polymorphisms with COPD pathophysiology, thereby possibly contributing to better treatments for this progressive and disabling disease in the future.